Search Results 731-740 of 19258 for Hemoglobin

1. Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET - Mayo Clinic

   * Hemoglobin (Hb) ≥ 8 g/dL * Creatinine clearance \> 40 mL/min calculated by the Cockcroft Gault method * Total bilirubin ≤ 3 x ULN * Potassium within ...

2. Trial Of Neoadjuvant Enoblituzumab Vs SOC In Men With High-Risk Localized Prostate Cancer - Mayo Clinic

   - Hemoglobin >9.0 g/dL - Platelet count >100,000 cells/mm3 - Serum creatinine <1.5 × upper limit of normal (ULN) - Serum bilirubin <1.5 × ULN - ALT <3 × ULN

3. Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA - Mayo Clinic

   Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable); Total bilirubin =< 1.5 x ...

4. Study to Investigate the Safety and Effectiveness of Two Doses of the Antibody Drug GSK2857916 in Relapsed/Refractory Multiple Myeloma Patients - Mayo Clinic

   Hemoglobin >=8.0 g/dL;; Platelets>= 50 X 10^9/L;; Total bilirubin <=1.5X Upper limit of normal (ULN). Isolated bilirubin >=1.5xULN is acceptable if bilirubin ...

5. Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy - Mayo Clinic

   -Hemoglobin >= 7.0 g/dL if asymptomatic or hemoglobin > 8 if symptomatic; transfusion support allowed, if necessary (obtained =< 14 days prior to registration).

6. A study of how current treatments impact the course of relapsed myeloma and the effect of the treatments on the quality-of-life measurements. - Mayo Clinic

   Hemoglobin > 8 g/dL;; Resolved acute effects of any prior therapy to baseline severity or Common Terminology Criteria for Adverse Events (CTCAE) Grade < 1 ...

7. A Study of BBI608 Combined with Standard Chemotherapies in Adult Patients who have Pancreatic Cancer - Mayo Clinic

   Hemoglobin (Hgb) ≥ 9 g/dl; Absolute neutrophil count ≥ 1.5 x 10^9/L; Platelets ≥ 100 x 10^9/L; Acceptable coagulation studies as demonstrated by prothrombin ...

8. A Study to Evaluate the Effect of Vitamin D on PFS in Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

   No cytopenias (platelets < 100,000/µl, hemoglobin < 10 g/dl, or absolute neutrophil count < 1500/µl). Exclusion Criteria: The following criteria will prevent ...

9. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Subjects With Warm Autoimmune Hemolytic Anemia (wAIHA) - Mayo Clinic

   - Hemoglobin (Hgb) level ≤10.0 grams/deciliter (pre-transfusion). - Evidence of classical complement pathway activation. - Evidence of active hemolysis ...

10. A Study of Ubenimex in Patients with Pulmonary Arterial Hypertension - Mayo Clinic

    Hemoglobin concentration <9 g/dL at screening; Hepatic dysfunction as defined by Child-Pugh Class B or C. Participating Mayo Clinic locations. Study statuses ...